FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

How to Find a Neuro Physical Therapist?
























Image Source: THEMEDICS

By Lisa Emrich

At some point on each of our journeys with MS, we may need the expert guidance from a physical therapist or physiologist. I was referred to PT after I began having difficulty standing up from a seated position. In PT, we learned that in addition to hip and leg weakness, I encountered a great deal of de-conditioning so part of my rehab was exercise to rebuild overall strength and stamina.
Read more »

Labels:


 

Walk To Celebrate Surviving With MS: VIDEO






















Fayetteville (KFSM) -- 5NEWS Anchor Daren Bobb sits down with Arkansas M. S. Development Director Sarah Miller and David Lawler to discuss the upcoming Walk MS: Northwest Arkansas.  The walk is a celebration of surviving and thriving while living with multiple sclerosis. The event takes place Saturday, May 7, at Lake Fayetteville.

Story Source: The above story is based on materials provided by 5NEWSONLINE
Note: Materials may be edited for content and length

Labels:


 

European Program Aims to Develop Wearable Devices to Monitor and Treat MS



































A major new European research program to develop ways of monitoring three main central nervous system diseases —MS, depressive disorder, and epilepsy — using wearable devices and smartphones was launched on April 26. The RADAR-CNS (Remote assessment of disease and relapse Central Nervous System) project, supported by the Innovative Medicines Initiative (IMI), aims to improve people’s quality of life and potentially change how a range of chronic disorders are treated.
Read more »

 

Rebound Syndrome in Patients With MS After Cessation of Gilenya (Fingolimod) Treatment: STUDY























Image Source: AMSEL

Importance  The appropriate sequencing of agents with strong immune system effects has become increasingly important. Transitions require careful balance between safety and protection against relapse. The cases presented herein highlight that rebound events after ceasing fingolimod treatment may happen even with short washout periods (4 weeks) and may perpetuate despite steroid treatment or the immediate use of fast-acting immune therapies, such as rituximab.
Read more »

Labels: ,


 

Investigation of cerebral microbleeds in MS as a potential marker of blood-brain barrier dysfunction: STUDY




















Image Source: EUROPEANSOCIETYOFRADIOLOGY
Read more »

Labels:


Monday

 

Why It Pays to Complain About Your High Medical Bills
















By Kim Dolce

It was the last straw. I’d opened a medical bill for 83 dollars–for a free PAP/pelvic exam. I felt my face grow hot and my blood pressure blow out of the top of my head.
Read more »

Labels:


 

From Vancouver, an Update on MS: VIDEO
























Dr. Robert Fox and Dr. Stephen Krieger

Long-term Follow-up of Clinical Trials

Stephen Krieger, MD: Hello. I'm Dr Stephen Krieger, associate professor of neurology at the Icahn School of Medicine at Mount Sinai in New York. Today I'm at the American Academy of Neurology 2016 Annual Meeting in Vancouver with Dr Robert Fox, staff neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic. Welcome, Dr Fox.
Read more »

Labels:


 

Biogen, AbbVie MS drug wins EU green light
























A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange

A once-monthly injection for multiple sclerosis from Biogen and AbbVie has been recommended for approval by European regulators, paving the way for its launch in the coming months.
Read more »

 

Cognitive Difficulties Known to MS Traced to Problems in Nerve Cell Activity in Hippocampus
























In a study published in the International Neurology Journal, researchers showed that cognitive deficits, such as memory problems, in a rat model of multiple sclerosis (MS) are mirrored by changes in synaptic transmission and plasticity in the hippocampus, a brain region crucial for memory processing. The findings advance the understanding of disease mechanisms affecting cognition in MS patients.
Read more »

Labels: ,


 

Lesion filling effect in regional brain volume estimations: a study in MS patients with low lesion load: STUDY
























Image Source: MRBRAINLESIONS
Read more »

Labels:


Sunday

 

Every Victory is a Victory





















Image Source: LIBCOM

By Matt Allen G

One of the most difficult parts of living with multiple sclerosis (for many of us) is probably accepting that we may no longer be able to do some of the things that we used to be able to do. This really drives me mad even though I have come to terms with many of my physical and mental disabilities MS has brought about. But it’s not as simple as that, you see, relapsing-remitting MS is a very dynamic disease in that it can always get better or get worse and for some of us that may be more frequent. You finally come to terms with your new baseline or your new “normal” and then? Then you have a relapse and everything is just terrible but the worst part is, even when you get over a relapse, when the waters settle, you may not be 100 percent back to your previous baseline. “Normal” for you has once again changed. Now you must learn to accept you new “normal” all over again.
Read more »

Labels:


 

The Ways an MS Diagnosis May Change Your Diet: VIDEO





While there’s no “MS diet” per se, a healthy diet is beneficial to everyone, especially those with a chronic illness. Here, Justin explains how living with MS has changed the way he eats.

Story Source: The above story is based on materials provided by EVERYDAYHEALTH
Note: Materials may be edited for content and length

Labels: ,


 

Importance of Early Intervention in MS: VIDEO




















Patricia K. Coyle, MD; Fred D. Lublin, MD; Claire S. Riley, MD and Clyde E. Markowitz, MD

The MD Magazine Peer Exchange “Strategies in the Management of Relapsing-Remitting Multiple Sclerosis” features a panel of physician experts discussing the importance of early therapy in multiple sclerosis treatment, factors that affect choice of  management strategy, the need for ongoing monitoring, and other aspects of treating patients with multiple sclerosis.
Read more »

Labels:


 

Menzies study looks at long-term benefits of MS treatment























Menzies’ MS researcher Bruce Taylor.

TASMANIAN researchers are embarking on a world-first investigation into whether existing drug treatments alter the long-term outcome for people with multiple sclerosis (MS).
Read more »

Labels:


 

OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in MS in Egyptian Patients: STUDY























Image Source: SARATOGA-OPTHALMOLOGY
Read more »

Labels:


Saturday

 

At MS Poker Night, All Bets Are Off

























By Trevis Gleason

There have been a lot of bright, shiny moments in my life. For a good long time after my diagnosis with multiple sclerosis it seemed that those sparkles of life were no longer in my cards, but they did come back.
Read more »

Labels:


 

A Way Forward in Treating Primary-Progressive MS?




























Image Source: MEDIMAGAZIN

The lack of a medication to treat primary-progressive multiple sclerosis (PPMS) is a source of frustration for clinicians and patients. The results of a recent phase 3 study of the drug ocrelizumab may be cause for hope.
Read more »

Labels: ,


 

Measures of Subtle Movements While Standing Detects Neurologic Problems in MS Patients and Athletes with Concussions






















Researchers at Purdue University have developed a method of identifying subtle oscillations in a person’s posture that mirror an excessive delay in neuromuscular responses, indicating a neurologic deficit. The oscillations, which differ from the normal tendency of a standing person to sway, may aid in diagnosing neuromuscular disorders such as MS.
Read more »

 

MS disease activity link to food allergies studied































Multiple sclerosis disease activity link to food allergies has been studied. The findings of the study revealed that multiple sclerosis patients with a history of food allergies show an increase in disease activity.
Read more »

Labels:


 

Fatigue and Comorbidities in MS: STUDY


























Image Source: WHATISLYME
Read more »

Labels: ,


Friday

 

Caution: Exercises Ahead















By Laura Kolaczkowski

Have you seen the ads running online these days that promote ten exercises for people with MS? Or ad that touts the eight ways for people with MS to strengthen our core and improve our balance? You probably have if you are on Facebook at all because they pop up regularly and they make me pause and question ‘what are they thinking!?’
Read more »

Labels:


 

Boston man with MS reaches new heights with support partner































Brian Moore-Ward
Image Source: HEALTHPROFESSIONALRADIO

Brian Moore-Ward recently climbed to the top of Boston’s tallest building to raise awareness for multiple sclerosis (MS). He has conquered this 60-flight climb seven years in a row.
Read more »

Labels:


 

Harsh out of necessity





































Image Source: CARCRASHLAWYER

To cope with multiple sclerosis, patients become morally stricter

Multiple Sclerosis affects nearly 2 and a half million people worldwide. It is a highly debilitating autoimmune disease: the condition severely reduces patients' quality of life through symptoms which disrupt motor, cognitive, and sensory systems. The disease, which in its most typical form is characterized by irregular remissions and acute attacks can create a state of increased anxiety in patients, and, according to scientists, can have negative cognitive/emotional effects as well, even influencing moral cognition in patients, as was observed in the recent study.
Read more »

 

Multiple Sclerosis Consortium Sets Up MS Clinical Trial Database of Patient Records for Research Use

























The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) is making available to qualified researchers a new database containing almost 2,500 records of patients who were part of the placebo groups of nine MS studies.
Read more »

Labels:


 

Alterations of the optic pathway between unilateral and bilateral optic nerve damage in MS as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials: STUDY



























Visual Evoked Potential Test
Image Source:  LOOKFORDIAGNOSIS
Read more »

Labels:


Thursday

 

Ocrelizumab PPMS Trial Data Released, Offers Reasons for Hope and Concern: VIDEO





































Image Source: MULTIPLESCLEROSISNEWSTODAY

By Marc Stecker-Wheelchair Kamikaze

Last month, at the annual ACTRIMS (American Committee for Treatment and Research in Multiple Sclerosis) conference, the full trial results for the Ocrelizumab PPMS drug trial were finally revealed. These results had been much anticipated by the MS community, as there are currently no proven effective treatments for primary progressive multiple sclerosis, and many previous PPMS drug trials have ended in failure.
Read more »

Labels: , , ,


 

At-Home ‘Brain Training’ Program for MS Patients Reported to Improve Cognitive Skills by 29%




























Multiple sclerosis patients using a cognitive remediation computer training program, part of a controlled trial by researchers from NYU Langone Medical Center, had greater improvements in cognitive function than those who used a placebo-training program, according to a presentation at the recent American Academy of Neurology annual meeting in Vancouver, Canada.
Read more »

Labels:


 

MS clinical trials – fighting for a cure






















To support the Multiple Sclerosis Trust’s Awareness Week 2016 the ISRCTN registry is exploring what’s new in the world of multiple sclerosis related clinical trials, and taking a look at some of the innovative studies in the registry.
Read more »

Labels:


 

Drug boosts myelin regeneration in mice raising hope of future treatments for MS





























A new treatment for people suffering from MS may be on its way, scientists claim, after tests on mice showed promising results. The drug fluorosamine – not yet approved for use in humans – has the potential to boost myelin regeneration, a key step in curing patients.
Read more »

Labels:


 

Effects of motor-motor and motor-cognitive tasks on balance in patients with MS: STUDY




































Image Source: CLIPARTPANDA
Read more »

Labels:


Wednesday

 

Men vs Women & Comorbidities























Image Source: MIRAGEWORLDOFWOMEN

By Laura Kolaczkowski

As if it’s not enough for so many of us to have multiple sclerosis, researchers from Canada have found evidence that we also have more than our fair share of other chronic diseases (comorbidities) to go with our MS. In a newly published study, Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study, a research team led by Ruth Ann Marrie, MD, looked at the health conditions of over 23,000 people with MS at the time of their diagnosis compared to 116,638 people as matched controls (same sex and same age, but without multiple sclerosis). Their report focuses on the comorbidities of people who also have MS.
Read more »

 

Primary-Progressive MS Sleep Issues























Over half of people diagnosed with MS have sleeping problems. Fatigue is also one of the most common and persistent symptoms. While getting tired from time to time is normal for everyone, this extreme feeling of overexertion persists for those with MS.
Read more »

Labels:


 

The Stages of Adjusting to a Diagnosis of MS




























There is no right or wrong way to adjust to a diagnosis of multiple sclerosis (MS.) Learning you have a chronic disease can bring up a number of emotions - fear, anger, denial, grief or guilt. Just as each person experiences the symptoms of MS differently, each person will also react to the diagnosis in their own unique way.
Read more »

 

Wrapping up MS
























Stephen Hauser, MD, the inaugural director of the new UCSF Weill Institute for Neurosciences, recently announced a breakthrough in his MS research that could change the lives of hundred of thousands of patients living with the neurological disease. Credit: Barbara Ries

With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn't stand a chance.
Read more »

 

A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial: STUDY





























Image Source: VANDERFILTUNIVERSITY
Read more »

Labels: ,


Tuesday

 

What to Do When You’re Ready to Quit Smoking




























Image Source: ALQURANCLASSES

By Kim Dolce

You’ve read the studies on smoking and MS risk. Heck, you’ve read a lot of information about the negative effects of smoking. You’re a one- or two-pack a-day smoker and have been for a long time, you have MS, and your doctor has been telling you to quit for years. Now you think you’d like to try. But how do you do it?
Read more »

Labels:


 

Virtual reality game helps patients with MS: VIDEO























Virtual reality has been incorporated into physical therapy programs for quite some time. Now, a UTSA faculty member is using the technology in therapy pools to help people with multiple sclerosis.
Read more »

Labels:


 

New database for sharing MS clinical trial data








Image Source: CRITICALPATHINSTITUTE

A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators. This is just one of the tools generated through the Multiple Sclerosis Outcome Assessments Consortium (MSOAC), a global effort launched by the National MS Society and Critical Path Institute (C-Path). MSOAC is striving to develop an outcomes measure that addresses the critical need for a more sensitive way to detect the benefit of potential treatments that slow or reverse progressive disability in people with MS.
Read more »

Labels:


 

The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with MS: STUDY



















Image Source: pppmag.com
Read more »

Labels:


 

The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with MS: study protocol for a randomised controlled trial: STUDY





























Image Source: MULTIPLE-SCLEROSIS-RESEARCH
Read more »

Labels:


Monday

 

MS Icebergs: What’s Going on in 90 Percent That Lies Beneath?






















At a meeting a few months ago, someone referred to multiple sclerosis as an “iceberg disease.” I jotted down a note to help me remember to write a blog about that idea. In shuffling through a file this week I ran across that note and I thought about it for a while.
Read more »

Labels:


 

MS: Taking Care of It and Living With It



























Julie Sancibrian
Photo by Karen Pike


Medical Therapies for Multiple Sclerosis

Proven studies still show that there is no single cause or cure for multiple sclerosis. Eighty  percent of patients with multiple sclerosis are diagnosed with remitting-relapsing, which means there is a recovery time (remitting) after experiencing symptoms (relapsing). A variety of treatments and therapies are available to help prevent relapses that would cause disability. However, if a patient is in one of the progressive stages, which means there is no recovery period and disability is present, then the only treatment, right now, are those to administer relief from symptoms such as pain and bladder problems.
Read more »

Labels:


 

Raising Awareness About Color Loss as a Potential Early Symptom of MS

























Color Vision Test Chart
Image Source: SMARTBRANDINGCO

An optometry practice in Mt. Pleasant, PA, H. Arnold Papernick OD, is raising awareness about the possibly of degrading color vision being an early warning sign of MS. The practice offers advanced eye functioning tests and exams, including color vision tests, which can potentially detect early signs of such issues.
Read more »

 

Editorial: Don't repeal protections against step therapy




























Sen. Jim Denning, R-Overland Park, center, helped speed up a bill regarding step therapy in February.
Image Source: THE CAPITAL-JOURNAL

Legislature shouldn't interfere with doctor-patient relationship

By The Capital-Journal Editorial Board
Imagine if your daughter was diagnosed with a terrifying, debilitating disease like multiple sclerosis. You consult with her doctor at length, consider an array of treatment options and finally choose one that proves effective.
Read more »

 

Tysabri (Natalizumab)-induced POU2AF1/Spi-B upregulation: STUDY

Sunday

 

MULTIPLE SCLEROSIS SUCKS!



















By Marc Stecker-Wheelchair Kamikaze

Allow me to apologize in advance for the contents of this essay. Quite simply, I’m fed up with multiple sclerosis and everything that has to do with multiple sclerosis. Those expecting to find any form of eloquence, wisdom, inspiration, or other redeeming qualities in these words will probably be sorely disappointed. Like a bulimic who just polished off a giant platter of lasagna, I’m feeling the need to purge and I have a hunch the results won’t be pretty. What follows promises to be more of a free-form rant than well-constructed discourse. I can’t guarantee any kind of narrative flow or grammatical cohesion, much less literary flourish or clever turn of phrase. No, instead I’m just gonna let it rip, an unadulterated regurgitation of everything about MS that’s been stuck in my craw these last few months. This may not be for the faint of heart, as I just might wander into some very uncomfortable territory. Okay, you’ve been warned; now’s the time to either buckle up or head for the exits.
Read more »

Labels: , ,


 

My Top 5 MS Food Hacks





























I just picked up a T-shirt that says, “Eat Well and Travel Often.” It was obviously made just for me. Traveling to new places and seeing new things is something I enjoy tremendously. And enjoying delicious meals makes me feel pampered and cared for. But since I can’t travel to exotic destinations every week, eating well is something I spend more of my time thinking about.
Read more »

 

Biogen and AbbVie Present New Data Showing Zinbryta, an RRMS Drug Candidate, Aids Cognition Without Immune Depletion
































New data presented by Biogen and AbbVie at the recent 68th annual meeting of the American Academy of Neurology (AAN) showed that Zinbryta (daclizumab high-yield process) improved cognitive outcome measures in patients with relapsing forms of multiple sclerosis (RMS).
Read more »

 

A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for MS: The MusiQoL-MCAT: STUDY























Image Source: MDA/ALSNEWSMAGAZINE
Read more »

Labels:


 

The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with MS: A Pilot Study: STUDY
























Image Source: NANDA-DIAGNOSIS
Read more »

Labels:



Go to Older News